Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapiesDenise M. Wolf, Laura van ‘t Veer, Christina Yau et al.|Cancer Cell|2022Cited by 335
Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breastMichael J. Campbell, Laura J. Esserman, Booyeon J. Han et al.|Breast Cancer Research and Treatment|2016Cited by 110